Kirkland & Ellis advised LucyRx, a fast-scaling, independent, next-generation pharmacy benefit manager, in a strategic combination with Abarca Health to create the only modern, independent pharmacy benefit manager with the scale, technology and track record to credibly serve commercial and government clients of any size.
Combined, Abarca and LucyRx will provide prescription services to more than 9 million members across the United States. The transaction is subject to regulatory approvals and customary closing conditions.
The parties remain independently owned and operated until the transaction closes, which is expected in the third quarter of 2026
The Kirkland team included corporate lawyers Jon-Micheal Wheat, John Wilkes, Laura Nance and Joanna Cornwell; and tax lawyers Mike Conroy and Mike Carew.
